ATE121754T1 - Vakzine gegen bordetella. - Google Patents

Vakzine gegen bordetella.

Info

Publication number
ATE121754T1
ATE121754T1 AT90309614T AT90309614T ATE121754T1 AT E121754 T1 ATE121754 T1 AT E121754T1 AT 90309614 T AT90309614 T AT 90309614T AT 90309614 T AT90309614 T AT 90309614T AT E121754 T1 ATE121754 T1 AT E121754T1
Authority
AT
Austria
Prior art keywords
sequence
amino acid
pertussis
vaccine against
against bordetella
Prior art date
Application number
AT90309614T
Other languages
English (en)
Inventor
Ian George Charles
Court
Neil Fraser Fairweather
Michael Anthony Romanos
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898919940A external-priority patent/GB8919940D0/en
Priority claimed from GB909011358A external-priority patent/GB9011358D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE121754T1 publication Critical patent/ATE121754T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90309614T 1989-09-04 1990-09-03 Vakzine gegen bordetella. ATE121754T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB898919940A GB8919940D0 (en) 1989-09-04 1989-09-04 Vaccines
GB909011358A GB9011358D0 (en) 1990-05-21 1990-05-21 Vaccines

Publications (1)

Publication Number Publication Date
ATE121754T1 true ATE121754T1 (de) 1995-05-15

Family

ID=26295865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90309614T ATE121754T1 (de) 1989-09-04 1990-09-03 Vakzine gegen bordetella.

Country Status (6)

Country Link
US (1) US5976544A (de)
EP (1) EP0425082B1 (de)
JP (1) JP3060504B2 (de)
AT (1) ATE121754T1 (de)
DE (1) DE69018926T2 (de)
DK (1) DK0425082T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2646776B1 (fr) 1989-05-12 1994-06-03 Pasteur Institut Utilisation de preparations vaccinantes a base d'adenyl cyclase ou de bacteries les produisant en tant qu'antigenes protecteurs contre les effets des bordetella
GB9027901D0 (en) * 1990-12-21 1991-02-13 Wellcome Found Acellular vaccine
EP0565794A1 (de) * 1992-04-14 1993-10-20 British Biotech Pharmaceuticals Limited Induktion von CTL-Antworten
WO1995009649A1 (en) 1993-10-05 1995-04-13 Medeva Holdings B.V. Vaccine compositions
US7459524B1 (en) * 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
PL192016B1 (pl) 1998-11-30 2006-08-31 Cytos Biotechnology Ag Kompozycja, sposób wytwarzania sztucznego, uporządkowanego i powtarzalnego układu antygenu, zastosowanie kompozycji oraz kompozycja szczepionki
WO2001085208A2 (en) 2000-05-05 2001-11-15 Cytos Biotechnology Ag Molecular antigen arrays and vaccines
US7731980B2 (en) * 2000-10-02 2010-06-08 Emergent Product Development Gaithersburg Inc. Chlamydia PMP proteins, gene sequences and uses thereof
US7537772B1 (en) 2000-10-02 2009-05-26 Emergent Product Development Gaithersburg Inc. Chlamydia protein, gene sequence and the uses thereof
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
JP4726483B2 (ja) 2002-07-17 2011-07-20 サイトス バイオテクノロジー アーゲー 分子抗原アレイ
KR101228376B1 (ko) 2002-07-18 2013-01-31 사이토스 바이오테크놀로지 아게 합텐-캐리어 컨쥬게이트 및 그의 용도
DE60336902D1 (de) 2002-07-19 2011-06-09 Cytos Biotechnology Ag Impfstoffzusammensetzungen enthaltende amyloid beta 1-6 antigenarrays

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
EP0338170A1 (de) * 1988-04-19 1989-10-25 Institut Pasteur Immunschutz gewährendes antigenes Protein gegen pathogene Bakterien
US5000952A (en) * 1988-08-02 1991-03-19 The Board Of Trustees Of The Leland Stanford, Jr. University Polypeptide pertussis toxin vaccine

Also Published As

Publication number Publication date
EP0425082B1 (de) 1995-04-26
US5976544A (en) 1999-11-02
DE69018926T2 (de) 1995-08-24
JP3060504B2 (ja) 2000-07-10
DK0425082T3 (da) 1995-07-03
JPH03236399A (ja) 1991-10-22
DE69018926D1 (de) 1995-06-01
EP0425082A1 (de) 1991-05-02

Similar Documents

Publication Publication Date Title
DE69018926D1 (de) Vakzine gegen Bordetella.
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
KR100202128B1 (en) Vaccine against lyme disease
ATE106943T1 (de) Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie.
EP0500108A3 (en) Improved activation of recombinant proteins
ES555124A0 (es) Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas
SE9101838D0 (sv) Novel peptides and their use
NO895028D0 (no) Ny chimerisk transformerende vekstfaktor-beta.
NO971621D0 (no) Keratinocyttvekstfaktoranaloger
DE59712235D1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
EP0330700A4 (de) Menschlicher Prourokinase ähnliches Polypeptid.
DE3852105D1 (de) Verfahren zur herstellung von aprotinin und aprotinin-homologen in hefe.
YU200091A (sh) Delecioni mutanti ahasarezistentni na herbicide
DE3886443D1 (de) Menschliche Rhinoviruspeptide.
DK0732339T3 (da) Peptider fra HIV-gag-proteinet, fremstilling og anvendelse deraf
ATE346941T1 (de) Protein-disulfidisomerase-gen eines methylotrophen hefestammes
DE69128095D1 (de) Azelluläre impfstoffe
BR9006746A (pt) Peptideo fisiologicamente ativo e agente regulador do metabolismo de calcio
CA2087450A1 (en) Stable and bioactive modified somatotropins
CA2025938A1 (en) Cloning of the gene which codes for the pilinic subunit fim3 of bordetella pertussis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time